Fenfluramine and Autism
You are currently viewing this item in Basic level. Alternative information may be available in Intermediate or Advanced.
Ranking : 
Type(s) : Medication
Introduction
Fenfluramine hydrochloride is an indirect 5-HT receptor agonist that was used as an anoretic i.e. an appetite reduction drug, sold under the brand name Pondimin.
It was removed from sale in 1997 because of significant safety fears that it contributed to the development of cardiac valvular disease.
Some people believe that it was a beneficial intervention for some of the problems faced by people with autism, although this was disputed by others.
Further information
Please see the Advanced version of this page for more information about this intervention, including relevant research studies and details of how we will rank them.
Please note
Although we have yet to to evaluate this intervention, the fact that this drug was removed from sale because of significant safety fears means that we are unlikely to recommend its use.
Opinion
We are currently reviewing the research evidence on the use of fenfluramine for people with autism.
If you are aware of any research, or you would like to share your personal experiences of fenfluramine please email info@researchautism.net Thank you.
Further information
Please see the Advanced version of this page for more information about this intervention, including relevant research studies and details of how we will rank them.
Please note
Although we have yet to to evaluate this intervention, the fact that this drug was removed from sale because of significant safety fears means that we are unlikely to recommend its use.
Disclaimer
Please read our Disclaimer about this intervention.
Last Updated : 25/03/2013 Back to Top
